Back to Search
Start Over
EVIDENCE THAT AN ANTHRACYCLINE-ANTI-CD8 IMMUNOCONJUGATE, IDARUBICIN-ANTI-LY-2.1, PROLONGS HEART ALLOGRAFT SURVIVAL IN MICE
- Source :
- Transplantation. 55:484-489
- Publication Year :
- 1993
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 1993.
-
Abstract
- To examine the potential use of immunoconjugates of drugs and antibodies as immunosuppressive agents, mice were treated with a short course (4 days) of T-cell-specific anti-Ly-2.1 monoclonal antibody, or MAB conjugated to an anthracycline, idarubicin (IDA). The anti-Ly-2.1 MAB had no significant effect on the survival of BALB/c (Ly-2.2) heart allografts in CBA (Ly-2.1) mice, but was a potent immunosuppressive agent when coupled to IDA, with most grafts surviving for > 100 days following treatment with doses ranging from 10 to 120 micrograms IDA, covalently coupled to 1-8 mg MAB. IDA-MAB treated mice with long-surviving heart grafts showed donor-specific tolerance. They did not reject donor-type skin grafts (these survived for > 50 days), but rejected third-party skin in 10-14 days. Heart allografts in these mice survived for > 100 days. Allografts placed 30 days after treatment were rejected, showing a recovery of peripheral T cell function at this time. Newly derived thymic T cells were, however, not required for this recovery since adult thymectomized, IDA-MAB treated animals also recovered T cell function and rejected heart allografts. FACScan analysis of T cells from mice treated with 80 micrograms IDA-4 mg MAB, which had received a heart allograft, showed 95% T cell depletion in the spleen compared with ungrafted, IDA-MAB treated animals, and untreated controls with or without allografts. Splenic T cell depletion was however not significant in CBA mice immunosuppressed with the lower dose of 10 micrograms IDA-MAB. Thus rapid depletion of splenic T cells was not required for immunosuppression induced by IDA-MAB conjugates. However, the minor subpopulation of Ly-2+, which was activated by alloantigen while carrying IDA-MAB, may be depleted during the T cell response to the allograft, resulting in a state of alloantigen-specific tolerance in mice with long-surviving heart allografts.
- Subjects :
- Graft Rejection
Time Factors
Transplantation, Heterotopic
Vena Cava, Superior
CD8 Antigens
medicine.medical_treatment
T cell
Spleen
Pharmacology
Mice
hemic and lymphatic diseases
medicine
Animals
Antigens, Ly
Idarubicin
Aorta, Abdominal
Mice, Inbred BALB C
Transplantation
Chemotherapy
business.industry
Immunotoxins
Graft Survival
Antibodies, Monoclonal
Immunosuppression
Skin Transplantation
Immunoconjugate
Mice, Inbred C57BL
medicine.anatomical_structure
Immunology
Mice, Inbred CBA
Heart Transplantation
business
CD8
medicine.drug
Subjects
Details
- ISSN :
- 00411337
- Volume :
- 55
- Database :
- OpenAIRE
- Journal :
- Transplantation
- Accession number :
- edsair.doi.dedup.....9688507ee1277cb3f8e07bffec851017
- Full Text :
- https://doi.org/10.1097/00007890-199303000-00006